Ranking Invest

Liquidia Corporation

Segmento: Healthcare Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.

Indicadores Básicos

Valor de Mercado

$ 2.33 Bi

IVR

-0.10

IVR2

-0.13

Índices de Previsibilidade

Faturamento

0.16

Lucro

0.33

Margem

0.54

Índices de Tendência

Faturamento

0.37

Lucro

-10.18

Margem

-9.19

Índices de Endividamento

DIV/PAT

-0.44

DIV/L4T

0.17

Dívida Líquida

-$ 22.09 Mi

Patrimônio Líquido

$ 49.71 Mi

L4T

-$ 127.83 Mi

MM4T

-957.32%

Dívidas
Dividendos
Cotação: $27.11

Não há dados de histórico de dividendos para exibir.

Gráfico Lucro/Faturamento X Trimestre